June 10th, 2025
10:00 AM PT
From lab to commercialization: Navigate the evolving risks of life science companies
Life science companies face rapidly evolving risks—from navigating insurance needs during early funding stages to understanding international clinical trial requirements and adapting to the rise of AI in research and product development.
In this three-part webinar series, our experts will help you identify critical insurance considerations and risk mitigation strategies at every stage of your company’s growth. Each session is designed to address a distinct challenge in the life science ecosystem—whether you're moving toward clinical trials, preparing for an IPO, or integrating AI technologies.
We’ll break down:
- Essential coverages by growth stage
- Country-specific clinical trial requirements
- Real-world risks and insurance implications of AI in life sciences
Whether you’re an early-stage biotech company or preparing for commercialization, join us to gain actionable insights and stay ahead in this dynamic industry.
Webinar 1
Navigating Risk from Lab to IPO: A Guide to Insurance for Biotech Executives
In this session, we’ll walk through the key insurance and risk management milestones life science companies should prepare for as they move from early funding through clinical trials, IPO, and commercialization. Learn what coverages matter most at each stage, common pitfalls to avoid, and how to build a scalable insurance strategy that supports growth.
